The company crushed analyst profitability estimates, both for its trailing quarter and for its full-year guidance.

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results , with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue ...

Investors with a lot of money to spend have taken a bullish stance on West Pharmaceutical Servs (NYSE:WST). And retail traders should know. We noticed this today when the trades showed up on publicly ...

Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. After a strong start to 2025, U.S.

West Pharmaceutical Servs (NYSE:WST) will release its quarterly earnings report on Thursday, 2025-07-24. Here's a brief overview for investors ahead of the announcement. Analysts anticipate West ...

West Pharmaceutical Services, Inc. has shown lumpy financial performance, with declining revenue and profits from 2023 to 2024. Recent results show some stabilization, but profitability remains ...

West Pharmaceutical Services, Inc.'s Q2 results signal a return to growth, driven by strong demand for high-value products and GLP-1 agonist components. I am revamping my bullish thesis: GLP-1 drugs ...

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

NEW YORK, June 20, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ("West" or the ...

You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected]. CASE ALLEGATIONS: West Pharmaceutical designs, ...

West Pharmaceutical Servs (NYSE:WST) is preparing to release its quarterly earnings on Thursday, 2025-10-23. Here's a brief overview of what investors should keep in mind before the announcement.

Allspring Global Investments Holdings LLC cut its holdings in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 7.2% in the 4th quarter, HoldingsChannel reports. The fund owned 3,423 ...